The issue of Pharmaceuticals in the Environment (PiE) is an increasing public concern.  While manufacturing losses represent a small percentage of the overall API mass entering the environment, the PSCI is committed to addressing localized risks that may occur from pharmaceutical manufacturing operations.  Many companies are requiring that their facilities – and their major suppliers – establish estimates for API mass loss and the resulting Predicted Environmental Concentration (PEC) in the water body that ultimately receives a facility’s wastewater discharge.

The PSCI-endorsed method for estimating API mass loss is to follow a mass balance approach where the API inputs, outputs, and losses are accounted for, allowing the mass entering wastewater to be estimated. The PSCI has developed a set of detailed guidance documents on how to approach the mass balance calculations, including this presentation which provides an overview of:

• Our approach
• Our methodology
• Real-world examples

We were delighted to be joined on this webinar by:

• Elizabeth Girardi-Schoen, Global Environmental Sustainability Leader at Pfizer
• Jason Rushing, PE, Principal Engineer and PiE Subject Matter Expert at Arcadis
• Nolan Chase, EIT, Consultant and PiE Specialist at Arcadis

The recording is available here.

The slides used during the webinar are available for download below.

Participants are invited to share any feedback about this webinar by completing this survey.